{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:22:02Z","timestamp":1792668122836,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T00:00:00Z","timestamp":1191974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1038\/sj.npp.1301591","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T13:01:47Z","timestamp":1192021307000},"page":"2020-2032","source":"Crossref","is-referenced-by-count":46,"title":["Nasal Colivelin Treatment Ameliorates Memory Impairment Related to Alzheimer's Disease"],"prefix":"10.1038","volume":"33","author":[{"given":"Marina","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Sasabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Terashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadakazu","family":"Aiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,10]]},"reference":[{"key":"BF1301591_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1172\/JCI27120","volume":"116","author":"KR Bales","year":"2006","unstructured":"Bales KR, Tzavara ET, Wu S, Wade MR, Bymaster FP, Paul SM et al (2006). Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. J Clin Invest 116: 825\u2013832.","journal-title":"J Clin Invest"},{"key":"BF1301591_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/cne.902510209","volume":"251","author":"BJ Balin","year":"1986","unstructured":"Balin BJ, Broadwell RD, Salcman M, El-Kalliny M (1986). Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J Comp Neurol 251: 260\u2013280.","journal-title":"J Comp Neurol"},{"key":"BF1301591_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"R Bartus","year":"1982","unstructured":"Bartus R, Dean III RL, Beer B, Lippa AS (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408\u2013417.","journal-title":"Science"},{"key":"BF1301591_CR4","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","volume":"29","author":"C Benedict","year":"2004","unstructured":"Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J et al (2004). Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29: 1326\u20131334.","journal-title":"Psychoneuroendocrinology"},{"key":"BF1301591_CR5","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1172\/JCI118672","volume":"97","author":"DE Brenneman","year":"1996","unstructured":"Brenneman DE, Gozes I (1996). A femtomolar-acting neuroprotective peptide. J Clin Invest 97: 2299\u20132307.","journal-title":"J Clin Invest"},{"key":"BF1301591_CR6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0022-3565(24)37441-5","volume":"285","author":"DE Brenneman","year":"1998","unstructured":"Brenneman DE, Hauser J, Neale E, Rubinraut S, Fridkin M, Davidson A et al (1998). Activity-dependent neurotrophic factor: structure\u2013activity relationships of femtomolar-acting peptides. J Pharmacol Exp Ther 285: 619\u2013627.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301591_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/cne.902420410","volume":"242","author":"RD Broadwell","year":"1985","unstructured":"Broadwell RD, Balin BJ (1985). Endocytic and exocytic pathways of the neuronal secretory process and trans-synaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo. J Comp Neurol 242: 632\u2013650.","journal-title":"J Comp Neurol"},{"key":"BF1301591_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","volume":"49","author":"A Caccamo","year":"2006","unstructured":"Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A et al (2006). M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49: 671\u2013682.","journal-title":"Neuron"},{"key":"BF1301591_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00001756-199802160-00001","volume":"9","author":"SS Cheema","year":"1998","unstructured":"Cheema SS, Arumugam D, Murray SS, Bartlett PF (1998). Leukemia inhibitory factor maintains choline acetyltransferase expression in vivo. Neuroreport 9: 363\u2013366.","journal-title":"Neuroreport"},{"key":"BF1301591_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/jnr.20305","volume":"78","author":"T Chiba","year":"2004","unstructured":"Chiba T, Hashimoto Y, Tajima H, Yamada M, Kato R, Niikura T et al (2004). Neuroprotective effect of activity-dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo. J Neurosci Res 78: 542\u2013552.","journal-title":"J Neurosci Res"},{"key":"BF1301591_CR11","doi-asserted-by":"publisher","first-page":"10252","DOI":"10.1523\/JNEUROSCI.3348-05.2005","volume":"25","author":"T Chiba","year":"2005","unstructured":"Chiba T, Yamada M, Hashimoto Y, Sato M, Sasabe J, Kita Y et al (2005). Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and in vivo. J Neurosci 25: 10252\u201310261.","journal-title":"J Neurosci"},{"key":"BF1301591_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbrc.2006.02.184","volume":"343","author":"T Chiba","year":"2006","unstructured":"Chiba T, Yamada M, Sasabe J, Terashita K, Aiso S, Matsuoka M et al (2006). Colivelin prolongs survival of an ALS model mouse. Biochem Biophys Res Commun 343: 793\u2013798.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF1301591_CR13","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"216","author":"JT Coyle","year":"1983","unstructured":"Coyle JT, Price DL, DeLong MR (1983). Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 216: 1184\u20131190.","journal-title":"Science"},{"key":"BF1301591_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0304-3940(89)90100-6","volume":"102","author":"A Fisher","year":"1989","unstructured":"Fisher A, Brandeis R, Pittel Z, Karton I, Sapir M, Dachir S et al (1989). (+)-cis-2-methyl-spiro(1,3-oxathiolane-5,3\u2032) quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats. Neurosci Lett 102: 325\u2013331.","journal-title":"Neurosci Lett"},{"key":"BF1301591_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1073\/pnas.93.1.427","volume":"93","author":"I Gozes","year":"1996","unstructured":"Gozes I, Bardea A, Reshef A, Zamostiano R, Zhukovsky S, Rubinraut S et al (1996). Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc Natl Acad Sci USA 93: 427\u2013432.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1301591_CR16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0022-3565(24)39336-X","volume":"293","author":"I Gozes","year":"2000","unstructured":"Gozes I, Giladi E, Pinhasov A, Bardea A, Brenneman DE (2000). Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J Pharmacol Exp Ther 293: 1091\u20131098.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1301591_CR17","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1523\/JNEUROSCI.21-23-09235.2001","volume":"21","author":"Y Hashimoto","year":"2001","unstructured":"Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, Arakawa E et al (2001a). Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci 21: 9235\u20139245.","journal-title":"J Neurosci"},{"key":"BF1301591_CR18","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1073\/pnas.101133498","volume":"98","author":"Y Hashimoto","year":"2001","unstructured":"Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y et al (2001b). A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and A\u03b2. Proc Natl Acad Sci USA 98: 6336\u20136341.[Erratum in: Proc Natl Acad Sci USA 98: 12854, 2001].","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1301591_CR19","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1016\/j.lfs.2005.03.031","volume":"77","author":"Y Hashimoto","year":"2005","unstructured":"Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, Matsuoka M (2005). Involvement of tyrosine kinases and STAT3 in humanin-mediated neuroprotection. Life Sci 77: 3092\u20133104.","journal-title":"Life Sci"},{"key":"BF1301591_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1385\/JMN:28:3:303","volume":"28","author":"M Holtser-Cochav","year":"2006","unstructured":"Holtser-Cochav M, Divinski I, Gozes I (2006). Tubulin is the target binding site for NAP-related peptides: ADNF-9, D-NAP, and D-SAL. J Mol Neurosci 28: 303\u2013307.","journal-title":"J Mol Neurosci"},{"key":"BF1301591_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","volume":"11","author":"L Illum","year":"2000","unstructured":"Illum L (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11: 1\u201318.","journal-title":"Eur J Pharm Sci"},{"key":"BF1301591_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0014-2999(91)90125-A","volume":"194","author":"J Itoh","year":"1991","unstructured":"Itoh J, Nabeshima T, Kameyama T (1991). Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur J Pharmacol 194: 71\u201376.","journal-title":"Eur J Pharmacol"},{"key":"BF1301591_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbr.2004.04.012","volume":"155","author":"JH Jhoo","year":"2004","unstructured":"Jhoo JH, Kim HC, Nabeshima T, Yamada K, Shin EJ, Jhoo WK et al (2004). Beta-amyloid (1\u201342)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res 155: 185\u2013196.","journal-title":"Behav Brain Res"},{"key":"BF1301591_CR24","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1111\/j.0953-816X.2004.03397.x","volume":"19","author":"M Kawasumi","year":"2004","unstructured":"Kawasumi M, Chiba T, Yamada M, Miyamae-Kaneko M, Matsuoka M, Nakahara J et al (2004). Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice. Eur J Neurosci 19: 2826\u20132838.","journal-title":"Eur J Neurosci"},{"key":"BF1301591_CR25","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/psc.569","volume":"10","author":"G Krejcova","year":"2004","unstructured":"Krejcova G, Patocka J, Slaninova J (2004). Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci 10: 636\u2013639.","journal-title":"J Pept Sci"},{"key":"BF1301591_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00002826-200405000-00011","volume":"27","author":"RM Lane","year":"2004","unstructured":"Lane RM, Kivipelto M, Greig NH (2004). Acetylcholinesterase and its inhibition in Alzheimer disease. Clin Neuropharmacol 27: 141\u2013149.","journal-title":"Clin Neuropharmacol"},{"key":"BF1301591_CR27","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/sj.bjp.0704429","volume":"134","author":"T Mamiya","year":"2001","unstructured":"Mamiya T, Ukai M (2001). [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 134: 1597\u20131599.","journal-title":"Br J Pharmacol"},{"key":"BF1301591_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1527-3458.2006.00113.x","volume":"12","author":"M Matsuoka","year":"2006","unstructured":"Matsuoka M, Hashimoto Y, Aiso S, Nishimoto I (2006). Humanin and colivelin: neuronal-death-suppressing peptides for Alzheimer's disease and amyotrophic lateral sclerosis. CNS Drug Rev 12: 113\u2013122.","journal-title":"CNS Drug Rev"},{"key":"BF1301591_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"M Mattson","year":"2004","unstructured":"Mattson M (2004). Pathways towards and away from Alzheimer's disease. Nature 430: 631\u2013639.","journal-title":"Nature"},{"key":"BF1301591_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","volume":"706","author":"T Maurice","year":"1996","unstructured":"Maurice T, Lockhart BP, Privat A (1996). Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706: 181\u2013193.","journal-title":"Brain Res"},{"key":"BF1301591_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molmed.2004.01.001","volume":"10","author":"I Nishimoto","year":"2004","unstructured":"Nishimoto I, Matsuoka M, Niikura T (2004). Unravelling the role of humanin. Trends Mol Med 10: 102\u2013105.","journal-title":"Trends Mol Med"},{"key":"BF1301591_CR32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1046\/j.1440-1827.1999.00977.x","volume":"49","author":"Y Oda","year":"1999","unstructured":"Oda Y (1999). Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int 49: 921\u2013937.","journal-title":"Pathol Int"},{"key":"BF1301591_CR33","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa050151","volume":"352","author":"RC Petersen","year":"2005","unstructured":"Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S et al (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352: 2379\u20132388.","journal-title":"N Engl J Med"},{"key":"BF1301591_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1006\/geno.1996.4523","volume":"40","author":"EI Rogaev","year":"1997","unstructured":"Rogaev EI, Sherrington R, Wu C, Levesque G, Liang Y, Rogaeva EA et al (1997). Analysis of the 5\u2032 sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics 40: 415\u2013424.","journal-title":"Genomics"},{"key":"BF1301591_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0304-3940(02)00199-4","volume":"324","author":"H Tajima","year":"2002","unstructured":"Tajima H, Niikura T, Hashimoto Y, Ito Y, Kita Y, Terashita K et al (2002). Evidence for in vivo production of humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci Lett 324: 227\u2013231.","journal-title":"Neurosci Lett"},{"key":"BF1301591_CR36","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature01506","volume":"422","author":"N Takasugi","year":"2003","unstructured":"Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, Takahashi Y et al (2003). The role of presenilin cofactors in the gamma-secretase complex. Nature 422: 438\u2013441.","journal-title":"Nature"},{"key":"BF1301591_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"RG Thorne","year":"2004","unstructured":"Thorne RG, Pronk GJ, Padmanabhan V, Frey II WH (2004). Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127: 481\u2013496.","journal-title":"Neuroscience"},{"key":"BF1301591_CR38","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(06)68350-5","volume":"367","author":"B Winblad","year":"2006","unstructured":"Winblad B, Kilander L, Eriksson S, Minthon L, Batsman S, Wetterholm AL, et al, Severe Alzheimer's Disease Study Group (2006). Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet 367: 1057\u20131065.","journal-title":"Lancet"},{"key":"BF1301591_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.bjp.0702309","volume":"126","author":"K Yamada","year":"1999","unstructured":"Yamada K, Tanaka T, Mamiya T, Shiotani T, Kameyama T, Nabeshima T (1999). Improvement by nefiracetam of \u03b2-amyloid-(1\u201342)-induced learning and memory impairments in rats. Br J Pharmacol 126: 235\u2013244.","journal-title":"Br J Pharmacol"},{"key":"BF1301591_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbr.2005.03.026","volume":"164","author":"M Yamada","year":"2005","unstructured":"Yamada M, Chiba T, Sasabe J, Nawa M, Tajima H, Niikura T et al (2005). Implanted cannula-mediated repetitive administration of Abeta25\u201335 into the mouse cerebral ventricle effectively impairs spatial working memory. Behav Brain Res 164: 139\u2013146.","journal-title":"Behav Brain Res"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1301591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301591","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T14:43:08Z","timestamp":1737470588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,10]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["BF1301591"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301591","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,10]]}}}